Among these, PET radiotracers targeting the 18 kDa translocator protein (TSPO) have been traditionally and widely used to assess neuroinflammation by visualizing microglial activation in AD, PD, and other neurodegenerative disorders. This evidence concerns the gene TSPO and Parkinson disease.